1US Food and Drug Administration. Drug approval drug ap- proval package Vizamyl (flutemetamol F18 injection) [ EB/ OL]. [2013 - 10 -25 ]. http://www, fda. gov/NewsEvents/ Newsroom/PressAnno-uncements/ucm372261. htm.
2STOREY A E, JONES C L, BOUVET D R C, et al. Fluorina- tion process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents: WO, 2007020400 [ P ]. 2007 - 02 - 22.
3SWAHN B M, SANDELL J, PYRING D, et al. Synthesis and evaluation of pyridylbenzofuran, pyridylbenzothiazole and py- ridylbenzoxazole derivatives as 18F-PET imaging agents for β- amyloid plaques [ J ]. Bioorg Med Chem Lett,2012,22 ( 13 ) : 4332 - 4337.
4WALKER Z, INGLIS F, SADOWSKY C, et al. Reproducibili- ty of [ 18F] flutemetamol petamy loid image interpretation [ J]. J Neur Sci,2013, (333) :352.
5KLUNK W E, MATHIS J, CHESTER A, et al. Benzothiazole derivative compounds compositions and uses: WO, 2004083195A1 [ P ]. 2004 - 09 - 30.
